Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Related to PolyMedix since IPIX aka CTIX acquired Brilacidin in 2013

PolyMedix had several issues...running out of funds was one. Leo acquired Brilacidin out of Bankruptcy court.

When this company ran the ph2b ABSSSI trial they used lower dosing to avoid some issues PolyMedix had with higher dosing.

I don't know whether the PolyMedix trial was stopped due to lack of funds or dosing issues.







Message in reply to:

What was this about?

Randomized, Dose Ranging, Active Controlled Efficacy and Safety Evaluation of PMX-30063 As Initial Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Staphylococcus aureus Phase 2 Prematurely Ended 2012-01-17